Hi - Just wondering if anyone has had the following comments on their BMB Report -
Clinical Notes: CML Progress on Glivec
13/07/10 09/08/10 29/11/10
Specimen: Bone Marrow Bone Marrow
Quantitative See Comment See Comment
Comment: BCR-ABL not detected in submitted sample. Note control gene copy number was borderline indicating suboptimal RNA quality / quantity. Assay sensitivity may be affected. Suggest repeat testing. Minimum sensitivity of qualitative assay is one abnormal cell in 10*5.Minimum sensitivity of quantitative assay is one abnormal cell in 10*4.
My new GP is trying to get an answer from the group where my Hematologist works out of - unfortunately he is on holiday and I don't get to see him again till end of May. Not sure if this means I have to keep having BMB, they seem to keep saying I need repeat testing. I think they are trying to get a benchmark for it?